Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$0.82 - $1.35 $34,358 - $56,565
41,900 New
41,900 $37,000
Q2 2023

Jul 21, 2023

SELL
$1.12 - $1.49 $2,800 - $3,725
-2,500 Reduced 35.71%
4,500 $5,000
Q2 2022

Jul 15, 2022

BUY
$1.13 - $3.69 $2,260 - $7,380
2,000 Added 40.0%
7,000 $10,000
Q1 2022

Apr 26, 2022

BUY
$2.85 - $3.73 $8,550 - $11,190
3,000 Added 150.0%
5,000 $16,000
Q4 2021

Jan 19, 2022

SELL
$3.24 - $5.18 $4,131 - $6,604
-1,275 Reduced 38.93%
2,000 $7,000
Q3 2021

Oct 27, 2021

BUY
$3.94 - $5.84 $8,963 - $13,286
2,275 Added 227.5%
3,275 $17,000
Q1 2021

Sep 07, 2021

BUY
$5.03 - $8.8 $5,030 - $8,800
1,000 New
1,000 $6,000
Q4 2020

Sep 07, 2021

SELL
$4.04 - $5.31 $6,060 - $7,964
-1,500 Closed
0 $0
Q3 2020

Sep 07, 2021

BUY
$3.64 - $7.76 $5,460 - $11,640
1,500 New
1,500 $6,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $177M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.